Clinical trial
Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
NCT00172159 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Neoadjuvant Therapy on the Resectability of Hepatic Metastases From Colorectal Cancers
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2000
- Completion date
- June 30, 2005
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer